In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA To Issue UDI Database Draft Guidance In March

This article was originally published in The Gray Sheet

Executive Summary

The draft guidance will serve as a user’s guide to the soon-to-be-released unique device identifier database, providing definitions for the device elements and attributes that companies have to submit to the database.


Related Content

FDA Reconsiders UDI Direct Marking Requirements For Implants
IMDRF Issues Proposed Guidances On Device Auditors, Global UDI System
Regulatory News In Brief
FDA To Issue Final Device Post-Market Surveillance Plan In February
Regulatory News In Brief
Final UDI Rule Date Uncertain, But Firms Should Prep Now, FDA Says
FDA’s UDI Draft Rule Details Device Marking, Database Submission Mandates





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts